Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis

被引:18
|
作者
Xu, Lei [1 ]
Yang, Chung S. [2 ]
Liu, Yanan [1 ]
Zhang, Xin [1 ]
机构
[1] Ningbo Univ, Dept Food Sci & Engn, Ningbo, Peoples R China
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Chem Biol, Piscataway, NJ 08854 USA
关键词
COVID-19; gut microbiota; probiotics; gut-lung axis; prebiotics; CHAIN FATTY-ACIDS; DIETARY FIBER; INTESTINAL MICROBIOTA; GREEN TEA; INFLAMMATION; INFECTION; POLYPHENOLS; MODULATION; DYSBIOSIS; IMMUNITY;
D O I
10.3389/fphar.2022.895193
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Coronavirus disease 2019 (COVID-19) can disrupt the gut microbiota balance, and patients usually have intestinal disorders. The intestine is the largest immune organ of the human body, and gut microbes can affect the immune function of the lungs through the gut-lung axis. Many lines of evidence support the role of beneficial bacteria in enhancing human immunity, preventing pathogen colonization, and thereby reducing the incidence and severity of infection. In this article, we review the possible approach of modulating microbiota to help prevent and treat respiratory tract infections, including COVID-19, and discuss the possibility of using probiotics and prebiotics for this purpose. We also discuss the mechanism by which intestinal micro-flora regulate immunity and the effects of probiotics on the intestinal micro-ecological balance. Based on this understanding, we propose the use of probiotics and prebiotics to modulate gut microbiota for the prevention or alleviation of COVID-19 through the gut-lung axis.
引用
下载
收藏
页数:12
相关论文
共 50 条
  • [41] Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support
    Giovanetti, Marta
    Pannella, Gianfranco
    Altomare, Annamaria
    Rocchi, Giulia
    Guarino, Michele
    Ciccozzi, Massimo
    Riva, Elisabetta
    Gherardi, Giovanni
    VIRUSES-BASEL, 2024, 16 (03):
  • [42] From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis
    Ahmadi Badi, Sara
    Tarashi, Samira
    Fateh, Abolfazl
    Rohani, Pejman
    Masotti, Andrea
    Siadat, Seyed Davar
    MEDIATORS OF INFLAMMATION, 2021, 2021
  • [43] Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
    Oh, Ki-Kwang
    Gupta, Haripriya
    Min, Byeong-Hyun
    Ganesan, Raja
    Sharma, Satya Priya
    Won, Sung-Min
    Jeong, Jin-Ju
    Lee, Su-Been
    Cha, Min-Gi
    Kwon, Goo-Hyun
    Jeong, Min-Kyo
    Hyun, Ji-Ye
    Eom, Jung-A
    Park, Hee-Jin
    Yoon, Sang-Jun
    Choi, Mi-Ran
    Kim, Dong Joon
    Suk, Ki-Tae
    CELLS, 2022, 11 (18)
  • [44] COVID-19 and Gut Microbiota: A Potential Connection
    Swati Rajput
    Deepanshu Paliwal
    Manisha Naithani
    Aashish Kothari
    Kiran Meena
    Satyavati Rana
    Indian Journal of Clinical Biochemistry, 2021, 36 : 266 - 277
  • [45] The gut microbiota in patients with COVID-19 and obesity
    Massip Copiz, Maria Macarena
    FASEB JOURNAL, 2021, 35
  • [46] COVID-19 and Gut Microbiota: A Potential Connection
    Rajput, Swati
    Paliwal, Deepanshu
    Naithani, Manisha
    Kothari, Aashish
    Meena, Kiran
    Rana, Satyavati
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2021, 36 (03) : 266 - 277
  • [47] Herbal Medicine, Gut Microbiota, and COVID-19
    Chen, Ziqi
    Lv, Yiwen
    Xu, Huachong
    Deng, Li
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [48] Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation
    Kaur, Harpreet
    Ali, Syed Azmal
    FOOD & FUNCTION, 2022, 13 (14) : 7423 - 7447
  • [49] Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability
    Liu, Qingqing
    Tian, Haixia
    Kang, Yongbo
    Tian, Yan
    Li, Lin
    Kang, Xing
    Yang, Hao
    Wang, Yanhong
    Tian, Jihua
    Zhang, Fan
    Tong, Mingwei
    Cai, Hongyan
    Fan, Weiping
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2021, 98
  • [50] CONSIDERATIONS FOR GUT MICROBIOTA AND PROBIOTICS IN PATIENTS WITH DIABETES AMIDST THE COVID-19 PANDEMIC: A NARRATIVE REVIEW
    Barengolts, Elena
    Smith, Emily Daviau
    ENDOCRINE PRACTICE, 2020, 26 (10) : 1186 - 1195